Tapan K Chaudhuri* and Richard Hoffler
Hampton, VA and San Antonio, TX, USA
*Corresponding Author: Tapan K Chaudhuri, Hampton, VA, USA. E-mail: email@example.com
Received: January 27, 2021; Published: January 30, 2020
If the use of Monoclonal Antibody (MoAb) to COVID-19 saved the life of the President of the United States and several other people in his circle, then why are we not using the same therapy for everybody else. If we aggressively motivate to start the use of MoAb to COVID-19 infection, we can prevent a lot of deaths. It’s a magic bullet, it’s a cure.
Citation: Tapan K Chaudhuri and Richard Hoffler. “Wide Spread Use of Monoclonal Antibody would have Prevented Massive Death Rate from Covid-19 Infection". Acta Scientific Pharmaceutical Sciences 5.2 (2021): 67.
Copyright: © 2021 Tapan K Chaudhuri and Richard Hoffler. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.